In many cancers, GSK3β inhibition leads to the β‐catenin buildup and translocation, promoting the transcription of oncogenes and tumor progression.[34] After analyzing the results of the mass spectrometry of the RNA pulldown products, derived from the probes specific for circFADS1 and the control probe, an interesting finding emerged: circFADS1 has the potential to bind GSK3β. Here, GSK3B is linked to cancer.